Jan Teller

Case Western Reserve University, Cleveland Heights, OH, United States 
"Jan Teller"
Mean distance: 106866
Cross-listing: Neuropathology Tree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Sanders HM, Lust R, Teller JK. (2009) Amyloid-beta peptide Abetap3-42 affects early aggregation of full-length Abeta1-42. Peptides. 30: 849-54
Nolan RL, Teller JK. (2006) Diethylamine extraction of proteins and peptides isolated with a mono-phasic solution of phenol and guanidine isothiocyanate. Journal of Biochemical and Biophysical Methods. 68: 127-31
Gambetti P, Parchi P, Capellari S, et al. (2001) Mechanisms of phenotypic heterogeneity in prion, Alzheimer and other conformational diseases. Journal of Alzheimer's Disease : Jad. 3: 87-95
Russo C, Schettini G, Saido TC, et al. (2001) N-terminal truncated amyloid β-peptides and Alzheimer's disease (multiple letters) Neurobiology of Aging. 22: 343-345
Russo C, Salis S, Dolcini V, et al. (2001) Amino-terminal modification and tyrosine phosphorylation of [corrected] carboxy-terminal fragments of the amyloid precursor protein in Alzheimer's disease and Down's syndrome brain. Neurobiology of Disease. 8: 173-80
Russo C, Schettini G, Saido TC, et al. (2000) Presenilin-1 mutations in Alzheimer's disease. Nature. 405: 531-2
Russo C, Angelini G, Dapino D, et al. (1998) Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 95: 15598-602
Russo C, Saido TC, DeBusk LM, et al. (1997) Heterogeneity of water-soluble amyloid beta-peptide in Alzheimer's disease and Down's syndrome brains. Febs Letters. 409: 411-6
Russo C, Gambelti P, Teller JK. (1997) N-terminally-modified water-soluble amyloid 3-peptides are aggregated in the brain but not in the cerebrospinal fluid Faseb Journal. 11: A974
Teller JK, Russo C, DeBusk LM, et al. (1996) Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome. Nature Medicine. 2: 93-5
See more...